SCHEMBL6557748

SCHEMBL6557748

Nc1ccc(CN2CCCCC(=O)C2)cc1

nearest known ligand 0.66

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.66
HRH3 Q9Y5N1 4/20 0.50
LMNA P02545 1/20 0.49
HRH4 Q9H3N8 1/20 0.46
KDM4E B2RXH2 1/20 0.44
MBTD1 Q05BQ5 1/20 0.43
L3MBTL3 Q96JM7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PARP1 P09874 1/20 0.43
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
NCF1 P14598 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559974 0.97 ALDH1A1 (0.61) ALDH1A1HRH3LMNAHRH4KDM4E
SCHEMBL6557554 0.90 ALDH1A1 (0.55) ALDH1A1HRH3LMNAKDM4ECYP2D6
SCHEMBL1366467 0.85 L3MBTL1 (0.54) HRH3LMNAHRH4L3MBTL1CYP2D6
SCHEMBL54966 0.82 ALDH1A1 (0.96) ALDH1A1HRH3LMNAHRH4KDM4E
SCHEMBL15500352 0.80 TNIK (0.50) ALDH1A1HRH3LMNAHRH4KDM4E
SCHEMBL3156543 0.80 ALDH1A1 (1.00) ALDH1A1HRH3LMNAHRH4KDM4E
Hydrochloric Acid SCHEMBL5529448 0.80 ALDH1A1 (0.92) ALDH1A1HRH3LMNAHRH4KDM4E
SCHEMBL62541 0.80 ALDH1A1 (1.00) ALDH1A1HRH3LMNAHRH4KDM4E
SCHEMBL10616916 0.80 ALDH1A1 (1.00) ALDH1A1HRH3LMNAHRH4KDM4E
Hydrochloric Acid SCHEMBL5521932 0.80 ALDH1A1 (0.92) ALDH1A1HRH3LMNAHRH4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP claimed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO claimed
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 EP disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 WO disclosed